Stock listing
Stuttgart:6JH0 IN8bio, Inc. Aktie
German listing (Stuttgart) of IN8bio, Inc. · home listing NASDAQ:INAB
Follow IN8bio, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:INAB
$0.816 USD -0.004 (-0.5%)
Close on Nov 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:INAB
- Day range
- $0.724 – $0.934 USDNov 16, 2026
- Volume
- 5.05M sharesNov 16, 2026
- Market cap
- $8.04M USDAt the close on Nov 16, 2026 · price × 9.86M shares outstanding
- 52-week range
- $0.724 – $2.730 USDLowest and highest trades, Nov 17, 2025 – Nov 16, 2026
- Traded on an average day
- $110,670 USDMedian day 31,800 shares · last 3 months, Aug 17, 2026 – Nov 16, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:INAB · Home | $0.816 USD | -0.004 (-0.5%) | 5,046,184 | $0.832 | $0.934 | $0.724 | $0.820 | Close on Nov 16, 2026 |
| Frankfurt:6JH0 | €0.745 EUR | +0.015 (+2.1%) | — | €0.730 | €0.745 | €0.730 | €0.730 | Close on Nov 16, 2026 |
Daily closes
Last 3 months, Aug 17, 2026 – Nov 16, 2026 · NASDAQ:INAB · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.816 | -0.004 | -0.5% | $0.832 | $0.934 | $0.724 | 5,046,184 | |
| $0.820 | 0.000 | 0.0% | $0.821 | $0.888 | $0.820 | 7,622 | |
| $0.820 | -0.051 | -5.9% | $0.880 | $0.880 | $0.805 | 16,064 | |
| $0.872 | -0.028 | -3.1% | $0.885 | $0.900 | $0.872 | 6,978 | |
| $0.900 | -0.040 | -4.3% | $0.980 | $0.990 | $0.900 | 12,754 | |
| $0.940 | +0.014 | +1.5% | $0.970 | $0.980 | $0.930 | 62,275 | |
| $0.927 | +0.097 | +11.6% | $0.969 | $1.000 | $0.880 | 33,375 | |
| $0.830 | -0.101 | -10.8% | $0.900 | $0.900 | $0.800 | 43,010 | |
| $0.931 | -0.019 | -2.0% | $0.940 | $0.970 | $0.920 | 107,526 | |
| $0.950 | +0.040 | +4.4% | $0.961 | $1.000 | $0.950 | 20,360 | |
| $0.910 | +0.009 | +1.0% | $0.928 | $1.000 | $0.910 | 9,321 | |
| $0.901 | -0.079 | -8.0% | $0.960 | $0.974 | $0.900 | 47,930 | |
| $0.980 | -0.040 | -3.9% | $1.010 | $1.010 | $0.980 | 1,415 | |
| $1.020 | +0.060 | +6.3% | $1.005 | $1.050 | $1.005 | 13,120 | |
| $0.960 | -0.006 | -0.6% | $0.931 | $0.991 | $0.931 | 12,197 | |
| $0.966 | -0.085 | -8.0% | $0.970 | $1.040 | $0.870 | 183,132 | |
| $1.050 | +0.064 | +6.5% | $1.020 | $1.079 | $1.018 | 10,300 | |
| $0.986 | -0.104 | -9.5% | $1.060 | $1.090 | $0.976 | 44,100 | |
| $1.090 | -0.050 | -4.4% | $1.160 | $1.160 | $1.050 | 32,200 | |
| $1.140 | +0.050 | +4.6% | $1.100 | $1.175 | $1.100 | 2,400 | |
| $1.090 | -0.020 | -1.8% | $1.110 | $1.174 | $1.070 | 21,500 | |
| $1.110 | -0.075 | -6.3% | $1.170 | $1.180 | $1.060 | 31,700 | |
| $1.185 | -0.015 | -1.2% | $1.209 | $1.235 | $1.170 | 9,800 | |
| $1.200 | +0.020 | +1.7% | $1.185 | $1.230 | $1.135 | 73,600 | |
| $1.180 | -0.050 | -4.1% | $1.250 | $1.260 | $1.180 | 62,700 | |
| $1.230 | -0.110 | -8.2% | $1.359 | $1.360 | $1.225 | 31,800 | |
| $1.340 | -0.040 | -2.9% | $1.360 | $1.380 | $1.340 | 13,100 | |
| $1.380 | -0.020 | -1.4% | $1.400 | $1.400 | $1.330 | 22,200 | |
| $1.400 | +0.010 | +0.7% | $1.380 | $1.410 | $1.360 | 20,700 | |
| $1.390 | -0.030 | -2.1% | $1.425 | $1.450 | $1.350 | 45,600 | |
| $1.420 | +0.020 | +1.4% | $1.430 | $1.450 | $1.380 | 107,100 | |
| $1.400 | 0.000 | 0.0% | $1.420 | $1.460 | $1.342 | 39,500 | |
| $1.400 | +0.070 | +5.3% | $1.360 | $1.460 | $1.360 | 78,500 | |
| $1.330 | +0.035 | +2.7% | $1.310 | $1.362 | $1.310 | 30,300 | |
| $1.295 | +0.055 | +4.4% | $1.280 | $1.300 | $1.270 | 62,200 | |
| $1.240 | +0.040 | +3.3% | $1.190 | $1.300 | $1.190 | 74,300 | |
| $1.200 | +0.010 | +0.8% | $1.180 | $1.270 | $1.170 | 67,600 | |
| $1.190 | +0.090 | +8.2% | $1.111 | $1.250 | $1.100 | 180,000 | |
| $1.100 | -0.040 | -3.5% | $1.150 | $1.150 | $1.100 | 22,600 | |
| $1.140 | +0.080 | +7.5% | $1.060 | $1.160 | $1.060 | 41,600 | |
| $1.060 | -0.020 | -1.9% | $1.090 | $1.110 | $1.060 | 13,800 | |
| $1.080 | +0.010 | +0.9% | $1.050 | $1.080 | $1.030 | 20,300 | |
| $1.070 | +0.060 | +5.9% | $1.030 | $1.100 | $1.030 | 48,000 | |
| $1.010 | -0.040 | -3.8% | $1.060 | $1.090 | $1.010 | 29,300 | |
| $1.050 | -0.060 | -5.4% | $1.100 | $1.100 | $1.010 | 70,900 | |
| $1.110 | +0.040 | +3.7% | $1.110 | $1.140 | $1.070 | 20,100 | |
| $1.070 | -0.030 | -2.7% | $1.120 | $1.130 | $1.060 | 37,000 | |
| $1.100 | +0.020 | +1.9% | $1.080 | $1.110 | $1.080 | 15,600 | |
| $1.080 | -0.060 | -5.3% | $1.100 | $1.125 | $1.080 | 21,500 | |
| $1.140 | -0.060 | -5.0% | $1.200 | $1.200 | $1.130 | 31,400 | |
| $1.200 | +0.040 | +3.4% | $1.160 | $1.220 | $1.160 | 22,400 | |
| $1.160 | +0.060 | +5.5% | $1.100 | $1.160 | $1.096 | 41,500 | |
| $1.100 | +0.010 | +0.9% | $1.090 | $1.110 | $1.085 | 6,700 | |
| $1.090 | -0.010 | -0.9% | $1.100 | $1.130 | $1.080 | 19,900 | |
| $1.100 | +0.065 | +6.3% | $1.010 | $1.130 | $1.010 | 36,900 | |
| $1.035 | -0.005 | -0.5% | $1.040 | $1.050 | $1.030 | 24,100 | |
| $1.040 | -0.145 | -12.2% | $1.190 | $1.190 | $0.960 | 130,300 | |
| $1.185 | +0.015 | +1.3% | $1.170 | $1.200 | $1.165 | 3,300 | |
| $1.170 | -0.010 | -0.8% | $1.180 | $1.200 | $1.110 | 58,728 | |
| $1.180 | -0.100 | -7.8% | $1.300 | $1.300 | $1.145 | 72,786 | |
| $1.280 | +0.070 | +5.8% | $1.230 | $1.300 | $1.180 | 105,500 | |
| $1.210 | +0.010 | +0.8% | $1.220 | $1.255 | $1.170 | 17,200 | |
| $1.200 | +0.060 | +5.3% | $1.160 | $1.260 | $1.155 | 79,100 | |
| $1.140 | +0.030 | +2.7% | $1.135 | $1.170 | $1.130 | 45,300 | |
| $1.110 | +0.010 | +0.9% | $1.110 | $1.140 | $1.052 | 37,000 |
Splits
1 split · NASDAQ:INAB · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-30 | Consolidation |
- Ticker
- Stuttgart:6JH0
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Stuttgart
- Currency
- EUR
What changed lately
Calls
Replays
IN8bio (NASDAQ:INAB) Q1 2022 Earnings Call
Tue, May 17, 2022 · 6:00 PM ET
Watch Transcript
Latest news
IN8bio Reports Updated Glioblastoma Data at SNO 2026 Demonstrating Median Overall Survival of 20.9 Months and 50% Two-Year Survival with Gamma-Delta T Cell Therapy
Nov 16, 2026
Closed $0.816 (-0.5%) on Nov 16, 2026
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Nov 6, 2026
Closed $0.94 (+1.5%) on Nov 9, 2026
IN8bio Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Nov 5, 2026
Closed $0.927 (+11.6%) on Nov 6, 2026
IN8bio to Present at H.C. Wainwright 28th Annual Global Investment Conference
Sep 10, 2026
Closed $1.10 (+1.9%) on Sep 10, 2026
IN8bio Appoints Oxana Polyakova, Ph.D., as Senior Vice President of Research & Development
Sep 9, 2026
Closed $1.08 (-5.3%) on Sep 9, 2026
IN8bio Reports Inducement Grant under Nasdaq Listing Rule 5635(4)
Aug 11, 2026
Closed $1.05 (+7.6%) on Aug 11, 2026
IN8bio Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Aug 6, 2026
Closed $0.979 (+0.9%) on Aug 7, 2026
IN8bio Announces Publication in The Journal of Clinical Oncology Demonstrating DeltEx™ DRI Doubles Progression-Free Survival in Newly Diagnosed Glioblastoma
Jul 9, 2026
Closed $1.40 (+1.4%) on Jul 9, 2026
IN8bio Announces Publication in Nature Communications Highlighting Advances in Gamma-Delta T Cell Engineering and Combination Therapies
Jun 3, 2026
Closed $1.54 (-1.3%) on Jun 3, 2026
IN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 2026
Jun 1, 2026
Closed $1.73 (-7.5%) on Jun 1, 2026
Financings
Private placement of common stock and pre-funded warrants
Dec 19, 2025
Announced: up to US$40.2M · US$1.38 a share · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Buyers: Coastlands Capital; Stonepine Capital Management; 683 Capital Partners, LP
Insiders: Directors and officers of the Company are participating.
Use of proceeds: IND enabling studies of INB-619, submitting INB-200 and INB-400 glioblastoma data to the FDA, working capital and general corporate purposes
Decks
Investor Presentation (2024)
Investor deck · 56 slides · 2024
IN8bio, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 21 in the last 12 months · 119 in all · newest Nov 16, 2026 · oldest 2021
- Calls
- 1 call with a replay · 1 with a transcript · latest May 17, 2022
- Decks
- 1 deck · latest 2024
Where IN8bio, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:INAB · Home listing | NASDAQ | United States | USD |
| LS Exchange:A4197Y | LS Exchange | Germany | EUR |
| BOATS:INAB | BOATS | United States | USD |
| gettex:6JH0 | gettex | Germany | EUR |
| Lang & Schwarz:A4197Y | Lang & Schwarz | Germany | EUR |
| Dusseldorf:6JH0 | Dusseldorf | Germany | EUR |
| Frankfurt:6JH0 | Frankfurt | Germany | EUR |
| Munich:6JH0 | Munich | Germany | EUR |
| Stuttgart:6JH0 · This page | Stuttgart | Germany | EUR |
| Tradegate:6JH0 | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about IN8bio, Inc.